Post Stroke Outcome: Global Insight into Persisting Sequelae Using the Post Stroke Checklist.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 28 10 2020
revised: 17 12 2020
accepted: 07 01 2021
pubmed: 26 1 2021
medline: 24 3 2021
entrez: 25 1 2021
Statut: ppublish

Résumé

Following stroke, individuals commonly experience persisting loss of function. Whilst long-term care should involve continued support for ongoing stroke sequelae, this is often not routinely practiced globally. The Post Stroke Checklist was designed to standardise the process of detecting persisting treatable problems following stroke. This cross-sectional study aimed to identify the long-term problems reported in Australian and Chinese participants at six months post stroke using the Post Stroke Checklist. It also aimed to provide global insight into poststroke sequelae by comparing the study results to previously published studies which administered the Post Stroke Checklist in other countries. Participants were recruited from two hospitals in Australia and one hospital in China. The Post Stroke Checklist consists of 11 problem areas commonly experienced after stroke. This study follows a sequence of studies which have applied the checklist to monitor long-term outcomes after stroke in Germany, Italy, Singapore, Sweden and the United Kingdom. Comparisons between Australia (n = 112) and China (n = 97) demonstrated statistically significant differences on the Post Stroke Checklist items. Across all seven countries, collectively the most common persisting difficulties post-stroke related to: cognition, life after stroke, mood, mobility and activities of daily living. An analysis of means procedure compared individual countries for each checklist item against the overall group mean (all countries combined). Globally, individuals report persisting functional difficulties following stroke. There appear to be differences in the proportions affected across the various countries, and healthcare systems may benefit from geographically tailoring post-stroke care.

Sections du résumé

BACKGROUND BACKGROUND
Following stroke, individuals commonly experience persisting loss of function. Whilst long-term care should involve continued support for ongoing stroke sequelae, this is often not routinely practiced globally. The Post Stroke Checklist was designed to standardise the process of detecting persisting treatable problems following stroke.
AIMS OBJECTIVE
This cross-sectional study aimed to identify the long-term problems reported in Australian and Chinese participants at six months post stroke using the Post Stroke Checklist. It also aimed to provide global insight into poststroke sequelae by comparing the study results to previously published studies which administered the Post Stroke Checklist in other countries.
METHODS METHODS
Participants were recruited from two hospitals in Australia and one hospital in China. The Post Stroke Checklist consists of 11 problem areas commonly experienced after stroke. This study follows a sequence of studies which have applied the checklist to monitor long-term outcomes after stroke in Germany, Italy, Singapore, Sweden and the United Kingdom.
RESULTS RESULTS
Comparisons between Australia (n = 112) and China (n = 97) demonstrated statistically significant differences on the Post Stroke Checklist items. Across all seven countries, collectively the most common persisting difficulties post-stroke related to: cognition, life after stroke, mood, mobility and activities of daily living. An analysis of means procedure compared individual countries for each checklist item against the overall group mean (all countries combined).
CONCLUSIONS CONCLUSIONS
Globally, individuals report persisting functional difficulties following stroke. There appear to be differences in the proportions affected across the various countries, and healthcare systems may benefit from geographically tailoring post-stroke care.

Identifiants

pubmed: 33493876
pii: S1052-3057(21)00014-8
doi: 10.1016/j.jstrokecerebrovasdis.2021.105612
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105612

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

John Olver (J)

Department of Rehabilitation, Epworth HealthCare, Melbourne, Australia; Department of Rehabilitation, Epworth Monash Rehabilitation Medicine (EMReM) Unit, Melbourne, Australia; School of Clinical Sciences, Monash University, Melbourne, Australia. Electronic address: john.olver@epworth.org.au.

Shanshan Yang (S)

Rehabilitation Department, Xuzhou Children's Hospital No.18, Jiangsu Province, China.

Bianca Fedele (B)

Department of Rehabilitation, Epworth HealthCare, Melbourne, Australia; Department of Rehabilitation, Epworth Monash Rehabilitation Medicine (EMReM) Unit, Melbourne, Australia; School of Clinical Sciences, Monash University, Melbourne, Australia.

Jun Ni (J)

Rehabilitation Department, the first Affiliated Hospital of Fujian Medical University, Fujian Province, China; Rehabilitation Department, the Affiliated Hospital of Nantong Medical University, Jiangsu Province, China. Electronic address: nijun1000@126.com.

Judith Frayne (J)

School of Clinical Sciences, Monash University, Melbourne, Australia; Department of Neurosciences and Van Cleef Roet Centre for Nervous Disease, Monash University, Melbourne, Australia.

Guangyu Shen (G)

Rehabilitation Department, the Affiliated Hospital of Nantong Medical University, Jiangsu Province, China.

Dean McKenzie (D)

Research Development and Governance Unit, Epworth HealthCare, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH